Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Sujith Samarasinghe

Newcastle AuthorsTitleYearFull text
Professor Anthony Moorman
Melvin Joy
Dr Amir Enshaei
Emerita Professor Christine Harrison
Dr Claire Schwab
et al.		De-intensifying post-induction therapy for patients with acute lymphoblastic leukaemia, good risk genetics and intermediate MRD at the end of induction2024
Ozcan Gulbey
Dr Amir Enshaei
Melvin Joy
Dr Sujith Samarasinghe
Professor Anthony Moorman
Early response refines end of induction measurable residual disease stratification in T-cell acute lymphoblastic leukaemia2024
Dr Ugo Offor
Dr Sujith Samarasinghe
Dr Kevin Windebank
Professor Mary Slatter
Professor Andrew Gennery
et al.		HSCT provides effective treatment for lymphoproliferative disorders in children with primary immunodeficiency2020
Dario Melguizo Sanchis
Dr Yaobo Xu
Dheraj Taheem
Dr Min Yu
Dr Katarzyna Tilgner
et al.		iPSC modelling of severe aplastic anemia reveals impaired differentiation and telomere shortening in blood progenitors2018
Dr Sarah Jenkinson
Dr Sujith Samarasinghe
Professor Anthony Moorman
Prognostic impact of the absence of biallelic deletion at the TRG locus for pediatric patients with T-cell acute lymphoblastic leukemia treated on the Medical Research Council UK Acute Lymphoblastic Leukemia 2003 trial2018
Dario Melguizo Sanchis
Dr Sujith Samarasinghe
Professor Lyle Armstrong
Professor Majlinda Lako
Concise review: Getting to the core of inherited bone marrow failures2017
Dr Amir Enshaei
Professor Christine Harrison
Dr Sujith Samarasinghe
Claire Schwab
Professor Anthony Moorman
Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia2017
Professor Anthony Moorman
Claire Schwab
Professor Christine Harrison
Dr Sujith Samarasinghe
Use of minimal residual disease assessment to redefine induction failure in pediatric acute lymphoblastic leukemia2017
Dr Sujith Samarasinghe
Professor Anthony Moorman
Early immature T-ALL as determined by absence of bi-allelic deletion at the TCR gamma locus is not an adverse prognostic factor on the MRC UKALL2003 trial2016
Professor Anthony Moorman
Dr Amir Enshaei
Dr Sujith Samarasinghe
Integrating Genetic Risk Factors with Age, Presenting White Cell Count and MRD Response As Continuous Variables to Predict Relapse in Paediatric Acute Lymphoblastic Leukemia (ALL)2016
Dr Peter Avery
Dr Sujith Samarasinghe
Central venous line placement prior to induction therapy in children with acute lymphoblastic leukaemia does not increase the risk of line-related thrombosis2015
Dr Amir Enshaei
Professor Anthony Moorman
Professor Christine Harrison
Dr Sujith Samarasinghe
Integration of Minimal Residual Disease with Other Patient Risk Factors Identifies a Population with Very Poor Overall Survival in Pediatric ALL: Results from the UKALL 2003 Trial2015
Dr Amir Enshaei
Professor Anthony Moorman
Professor Christine Harrison
Dr Sujith Samarasinghe
Long Term Overall Survival of Greater Than 98% in Childhood ALL Patients with Good Risk Features and Low Risk MRD: Results from a Large Multi-Center Randomized Controlled Trial, UKALL 20032015
Dr Amir Enshaei
Professor Anthony Moorman
Professor Christine Harrison
Dr Sujith Samarasinghe
Long Term Overall Survival of Greater Than 98% in Childhood ALL Patients with Good Risk Features and Low Risk MRD:A Results from a Large Multi-Center Randomized Controlled Trial, UKALL 20032015
Dr Nicholas Bown
Dr Sujith Samarasinghe
Professor Simon Bailey
Professor Roderick Skinner
FLT3 internal tandem duplication and NPM1 mutations in paediatric AML: a single centre experience2014
12